Albert D. Dyrness serves as Executive at Sonnet BioTherapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Albert D. Dyrness has executed 10 insider transactions totaling $20.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 9, 2026 involved receiving (via award) 40,789 shares valued at $0.
Albert D. Dyrness currently holds 41,671 shares of Sonnet BioTherapeutics Holdings, Inc. (SONN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Albert D. Dyrness has been a net buyer of SONN stock. They have purchased $20.6K and sold $0 worth of shares.
Albert D. Dyrness's most recent insider trade was on Feb 9, 2026, when they sold 40,789 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 2, 2025 | PURR | $0 | Other | 882 | $N/A | Discretionary |
| Jul 11, 2023 | SONN | $0 | Award | 4,000 | $N/A | Discretionary |
| May 30, 2023 | SONN | $10.9K | Purchase | 23,255 | $0.47 | Discretionary |
| Dec 14, 2022 | SONN | $0 | Award | 3,770 | $N/A | Discretionary |
| Dec 15, 2021 | SONN | $0 | Award | 14,152 | $N/A | Discretionary |
| Jul 2, 2020 | SONN | $0 | Award | 8,005 | $N/A | Discretionary |
| Jun 11, 2020 | SONN | $9.7K | Purchase | 2,409 | $4.01 | Discretionary |
| Apr 1, 2020 | SONN | $0 | Award | 2,557 | $N/A | Discretionary |